These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Ambitious measles vaccination program in Vietnam]. Björklund J; Strand M; Blennow M Lakartidningen; 2006 Apr 26-May 2; 103(17):1325-7. PubMed ID: 16708862 [No Abstract] [Full Text] [Related]
5. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation]. Zverev VV; Iuminova NV Vopr Virusol; 2004; 49(3):8-11. PubMed ID: 15188648 [TBL] [Abstract][Full Text] [Related]
6. Measles outbreak response vaccination in the Federated States of Micronesia. Gopalani SV; Helgenberger L; Apaisam C; Donre S; Takiri K; Charley J; Yomai A; Judicpa P; Nakazono N; Johnson E; Setik E; Taulung L; Elias A; Barrow-Kohler L Int J Epidemiol; 2016 Oct; 45(5):1394-1400. PubMed ID: 27272184 [No Abstract] [Full Text] [Related]
7. What will it take to achieve measles elimination in the World Health Organization European Region: progress from 2003-2009 and essential accelerated actions. Martin R; Wassilak S; Emiroglu N; Uzicanin A; Deshesvoi S; Jankovic D; Goel A; Khetsuriani N J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S325-34. PubMed ID: 21666181 [TBL] [Abstract][Full Text] [Related]
8. Strategic planning for measles control: using data to inform optimal vaccination strategies. Simons E; Mort M; Dabbagh A; Strebel P; Wolfson L J Infect Dis; 2011 Jul; 204 Suppl 1():S28-34. PubMed ID: 21666174 [TBL] [Abstract][Full Text] [Related]
9. Measles elimination: lack of progress in the Western Pacific Region. Masuno K; Shibuya K Lancet; 2009 Mar; 373(9668):1008. PubMed ID: 19304015 [No Abstract] [Full Text] [Related]
10. Progress toward measles elimination--region of the Americas, 2002-2003. Ann Pharmacother; 2004 Jun; 38(6):1108. PubMed ID: 15122007 [No Abstract] [Full Text] [Related]
11. Back to basics: the miracle and tragedy of measles vaccine. Jakab Z; Salisbury DM Lancet; 2013 Apr; 381(9876):1433-4. PubMed ID: 23623213 [No Abstract] [Full Text] [Related]
12. Letter to the editor: Measles cases among fully vaccinated persons. Arima Y; Oishi K Euro Surveill; 2018 Aug; 23(34):. PubMed ID: 30153884 [No Abstract] [Full Text] [Related]
13. Measles control in Yaounde: justification of a one dose, nine month minimum age vaccination policy in tropical Africa. Heymann DL; Mayben GK; Murphy KR; Guyer B; Foster SO Lancet; 1983 Dec 24-31; 2(8365-66):1470-2. PubMed ID: 6140558 [TBL] [Abstract][Full Text] [Related]
14. Genetic variability of wild-type measles viruses, circulating in the Russian Federation during the implementation of the National Measles Elimination Program, 2003-2007. Shulga SV; Rota PA; Kremer JR; Naumova MA; Muller CP; Tikhonova NT; Lopareva EN; Mamaeva TA; Tsvirkun OV; Mulders MN; Lipskaya GY; Gerasimova AG Clin Microbiol Infect; 2009 Jun; 15(6):528-37. PubMed ID: 19392887 [TBL] [Abstract][Full Text] [Related]
15. Preplanned national measles vaccination campaign at the beginning of a measles outbreak--Sierra Leone, 2009-2010. Sugerman DE; Fall A; Guigui MT; N'dolie M; Balogun T; Wurie A; Goodson JL J Infect Dis; 2011 Jul; 204 Suppl 1():S260-9. PubMed ID: 21666171 [TBL] [Abstract][Full Text] [Related]
16. [Progress towards the 2012 measles elimination goal in Japan]. Tanaka-Taya K Uirusu; 2010 Jun; 60(1):59-68. PubMed ID: 20848865 [TBL] [Abstract][Full Text] [Related]
18. Progress toward measles elimination--Japan, 1999-2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(38):1049-52. PubMed ID: 18818586 [TBL] [Abstract][Full Text] [Related]
19. Measles Elimination Activities in the Western Pacific Region: Experience from the Republic of Korea. Choe YJ; Jee Y; Oh MD; Lee JK J Korean Med Sci; 2015 Nov; 30 Suppl 2(Suppl 2):S115-21. PubMed ID: 26617443 [TBL] [Abstract][Full Text] [Related]